Phase II Trial of Neoadjuvant/adjuvant Imatinib Mesylate for Advanced Primary and Metastatic/recurrent Operable Gastrointestinal Stromal Tumors: Long-term Follow-up Results of Radiation Therapy Oncology Group 0132
2011 ◽
Vol 19
(4)
◽
pp. 1074-1080
◽
2012 ◽
Vol 19
(7)
◽
pp. 2420-2420
◽
Keyword(s):
Keyword(s):
2007 ◽
Vol 2007
◽
pp. 51-52
2006 ◽
Vol 18
(1)
◽
pp. 40-44
◽
2008 ◽
Vol 71
(5)
◽
pp. 1351-1355
◽
2007 ◽
Vol 69
(2)
◽
pp. S140
◽
2018 ◽
Vol 36
(15_suppl)
◽
pp. 8512-8512
◽